Ablation of Perimitral Flutter Following Catheter Ablation of Atrial Fibrillation: Impact on Outcomes

Completed · Phase 3

Conditions studied: Atrial Fibrillation, Perimitral Flutter

In brief

This prospective, randomized study aims to compare the impact of ablation of perimitral flutter only versus cardioversion and repeat isolation of pulmonary veins with ablation of additional triggers, on procedure outcome.

Key facts

Study ID

NCT01173796

Run by

Texas Cardiac Arrhythmia Research Foundation

People needed

44

Starts

2010-03-01

Expected to finish

2011-09-01

Last updated by the study team

2012-07-11

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with previous AF ablation presenting with PMFL and recurrent AF
• Age: 18- 75 years
• Willingness and ability to give written informed consent
• Therapeutic INR for at least 4 weeks prior to the procedure

You may not qualify if…

• Reversible causes of AF such as pericarditis and hyperthyroidism
• Documented intra-atrial thrombus, tumor or any other abnormality which prevents easy catheter manipulation
• Enrollment in another clinical study
• Any other terminal illness

Where it is running

• Texas Cardiac Arrhythmia Research Foundation — Austin, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.